JAK inhibitors show 81.7% treatment retention in adult patients with rheumatoid arthritis and interstitial lung disease
New data compares treatments for rheumatoid arthritis and lung disease
This network meta-analysis of 8,186 adult patients with rheumatoid arthritis and interstitial lung disease (RA-ILD) evaluated 14 pharmacolog…
A large review of over 8,000 patients helps identify which medications might best manage both joint pain and lung damage.
Dipyridamole combined with immunoglobulin and aspirin improves clinical efficacy in children with Kawasaki disease
Dipyridamole Combined with Aspirin Improves Outcomes for Kawasaki Disease
This meta-analysis of randomized controlled trials involving 1,594 children found that adding dipyridamole to immunoglobulin and aspirin sig…
Adding dipyridamole to standard immunoglobulin and aspirin treatment may improve clinical outcomes and speed up recovery for children with K…